Jeanne, Médéric
Vuillaume, Marie-Laure
Ung, Dévina C.
Vancollie, Valerie E.
Wagner, Christel
Collins, Stephan C.
Vonwill, Sandrine
Haye, Damien
Chelloug, Nora
Pfundt, Rolph
Kummeling, Joost
Moizard, Marie-Pierre
Marouillat, Sylviane
Kleefstra, Tjitske
Yalcin, Binnaz
Laumonnier, Frédéric http://orcid.org/0000-0003-2567-0708
Toutain, Annick
Funding for this research was provided by:
Association pour le développement de la neurogénétique
Fondation de France
Article History
Received: 17 July 2020
Accepted: 22 December 2020
First Online: 8 January 2021
Compliance with ethical standards
:
: On behalf of all authors, the corresponding author states that there is no conflict of interest.
: The study was approved by the local institutional review boards, and written informed consent was obtained from the patients’ parents, including explicit permission to share clinical and identifying information. All mouse experiments performed at the University of Tours/INSERM were approved by the French Ministry of Research (Project authorization number 01456.03). The care and use of <i>Hira</i><sup>±</sup> mice in the Wellcome Sanger Institute study was carried out in accordance with UK Home Office regulations, UK Animals (Scientific Procedures) Act of 1986 under two UK Home Office licences (80/2485 and P77453634) that approved this work, which were reviewed regularly by the Wellcome Sanger Institute Animal Welfare and Ethical Review Body.
: The study was approved by the local institutional review boards, and written informed consent was obtained from the patients’ parents, including explicit permission to share clinical and identifying information.
: The study was approved by the local institutional review boards, and written informed consent was obtained from the patients’ parents, including explicit permission to share clinical and identifying information.